发明名称 |
PHARMACEUTICAL COMPRISING PYRAZOLONE DERIVATIVE |
摘要 |
Disclosed is a pharmaceutical which is intended to be administered in such a form that can reduce a renal disorder exacerbated upon the administration of a pyrazolone derivative and an antibiotic in combination. A cerebral protective agent for use in a patient who receives the administration with an antibiotic, comprising a pyrazolone derivative (e.g., 3-methyl-1-phenyl-2-pyrazolin-5-one) or a physiologically acceptable salt thereof or a hydrate or solvate of the derivative or salt as an active ingredient, the pyrazolone derivative or physiologically acceptable salt thereof or the hydrate or solvate of the derivative or salt being administered subsequent to the administration of the antibiotic.
|
申请公布号 |
KR20080015123(A) |
申请公布日期 |
2008.02.18 |
申请号 |
KR20077030067 |
申请日期 |
2007.12.24 |
申请人 |
MITSUBISHI TANABE PHARMA CORPORATION |
发明人 |
MUTAI MAMORU;OHYAMA NAOKI;ISHII SHUNICHIRO;MORITA MIYUKI;INAGAKI KIYOHARU |
分类号 |
A61K31/4152;A61K31/546;A61P13/12;A61P25/28 |
主分类号 |
A61K31/4152 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|